Spotlight On... Researchers ID link between fish-flavored cat food and thyroid disease; Zoetis nabs USDA license for Lyme disease vaccine; Patterson hires Merial pro to lead companion animal group; Jaguar launches new Neonorm trial; and more...

Cats love fish, but a new study suggests their beloved flavor may be contributing to the rising rate of feline hyperthyroidism. Researchers in Japan have released a study in the journal Environmental Science & Technology suggesting that pollutants such as polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs), which occur naturally in fish, are being passed along to cats in their food and may be contributing to the thyroid disorder. The scientists took blood samples from cats, and found high levels of PCBs and PDBs, which they determined would be more likely to come from fish-flavored food than from other environmental exposures. They also built simulations to determine how the feline body reacts to PCBs and PBDs, so they can better determine how the chemicals affect thyroid function. Release

> Zoetis ($ZTS) announced that the USDA has licensed Vanguard crLyme vaccine, the first vaccine against canine Lyme disease that drives an immune response against surface protein C variability--a major cause of the disease. Release

> Patterson Companies ($PDCO) has hired Doug Jones, formerly of Sanofi's ($SNY) Merial, as president of its companion animal group. Release

> Jaguar Animal Health ($JAGX) announced that it has initiated a study with Cornell University College of Veterinary Medicine to examine the prophylactic use of Neonorm Calf in preweaned dairy cows. Release

> Scientists at University College London, the Zoological Society of London (ZSL) and the University of Edinburgh have released a map showing that West Africa, sub-Saharan Africa and South East Asia face the highest risk of viruses that are transmitted from bats to humans. Release

> ImmuCell ($ICCC) announced that it has acquired certain assets from Day 1 Technology for formulating bovine antibodies into an oral gel solution, which it will use to bolster its First Defense product line. Release

> Swedish scientists have published a study in the journal Genetics identifying genes found in fearful chickens that they believe may provide insight into anxiety disorders that also affect people. Release

> Kane Biotech announced it has formed a sales rep agreement with a U.S.-based firm in preparation for the launch of Bluestem, its pet oral care brand. Release

> Big Dog Natural has recalled a lot of its raw dehydrated dog food Chicken Supreme because of potential contamination with Salmonella and of its Fish Supreme because of potential contamination with Listeria monocytogenes. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…